SCHEMBL2862273

SCHEMBL2862273

CC(C)(C)OC(=O)n1nc(-c2cccc(F)c2)c2cc(CCl)ccc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K4 P45985 1/20 0.55
ICMT O60725 3/20 0.38
PTGER1 P34995 1/20 0.37
SLC16A3 O15427 1/20 0.35
SLC16A1 P53985 1/20 0.35
MCTS1 Q9ULC4 1/20 0.35
NR1H2 P55055 1/20 0.35
PDE4B Q07343 1/20 0.35
MAPT P10636 1/20 0.35
FAAH O00519 1/20 0.35
ELANE P08246 2/20 0.34
KDM4E B2RXH2 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
GPR119 Q8TDV5 1/20 0.34
CDK9 P50750 1/20 0.33
BCL2A1 Q16548 1/20 0.33
TRPA1 O75762 1/20 0.33
CTSS P25774 1/20 0.33
CTSK P43235 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2858091 0.91 MAP2K4 (0.56) MAP2K4ICMTPTGER1SLC16A3SLC16A1
SCHEMBL2863260 0.90 MAP2K4 (0.58) MAP2K4ICMTPTGER1SLC16A3SLC16A1
SCHEMBL13198131 0.90 MAP2K4 (0.55) MAP2K4ICMTPTGER1SLC16A3SLC16A1
SCHEMBL27538879 0.85 MAP2K4 (0.51) MAP2K4ICMTPTGER1SLC16A3SLC16A1
SCHEMBL2860870 0.85 MAP2K4 (0.61) MAP2K4ICMTPTGER1NR1H2ELANE
SCHEMBL2864259 0.84 PTGER1 (0.43) MAP2K4ICMTPTGER1PDE4BMAPT
SCHEMBL2871097 0.83 MAP2K4 (0.56) MAP2K4ICMTPTGER1NR1H2PDE4B
SCHEMBL2864722 0.81 MAP2K4 (0.55) MAP2K4MAPTELANE
SCHEMBL2861577 0.80 MAP2K4 (0.53) MAP2K4PTGER1MAPTKDM4E
SCHEMBL2859289 0.78 MAP2K4 (0.49) MAP2K4MAPTELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
CN-1300116-C 1H-indazole compounds EISAI CO LTD (JP) 2007-02-14 CN disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
CN-1512987-A Novel 1H-indazole compound ������������ʽ���� 2004-07-14 CN disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAP2K4 61/4885ICMT 3178/4885PTGER1 3143/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 MAP2K4 53/4885ICMT 2656/4885PTGER1 4240/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAP2K4 61/4885ICMT 3178/4885PTGER1 3143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.